✦ LIBER ✦

Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study

✍ Scribed by Darbà, Josep; Kaskens, Lisette; Sánchez-de la Rosa, Rainel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Glatiramer Acetate

✍ Darba, J.; Kaskens, L.; Sánchez-de la, R.osa R 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of fingolimod versus

✍ Lee, Soyon; Baxter, Daniel C.; Limone, Brendan; Roberts, Matthew S.; Coleman, Cr 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 382 KB

Efficacy, safety, and cost-effectiveness

✍ Boster, A.; Bartoszek, M. P.; O'Connell, C.; Pitt, D.; Racke, M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 160 KB

Cost-Effectiveness of Interferon Beta-1a

✍ Lisa A. Prosser; Karen M. Kuntz; Amit Bar-Or; Milton C. Weinstein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

PNP15: COST-UTILITY ANALYSIS OF THE TREA

✍ C Rubio-Terrés; F Medina; I Aristegui; G Izquierdo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PND8 COST-EFFECTIVENESS AND BUDGET IMPAC

✍ O Espallardo; C Crespo; C Polanco; D Nieves 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB